| Nov 13 |
Amgen shares sink on obesity drug concerns; AstraZeneca to spend $3.5B on manufacturing
|
| Nov 12 |
Centessa Pharmaceuticals GAAP EPS of -$0.37
|
| Nov 12 |
Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update
|
| Oct 12 |
Centessa Pharmaceuticals Plc (CNTA): A Small-Cap Leader in Clinical-Stage Biotech
|
| Oct 9 |
Analysts Rate Centessa Pharmaceuticals Plc (CNTA) as Strong Buy Amid Promising Developments
|
| Sep 26 |
Centessa Pharmaceuticals Presents Preclinical Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)
|
| Sep 25 |
Centessa Pharmaceuticals: Progressing SerpinPC Through Registrational Trials In Hemophilia B
|
| Sep 20 |
Centessa Pharmaceuticals rises after upgrade to Overweight at Morgan Stanley
|
| Sep 19 |
Centessa Pharmaceuticals a new buy at B Riley on sleep disorders pipeline
|
| Sep 13 |
Centessa Pharmaceuticals prices $225M equity offfering
|
